ArticleIndian journal of psychiatry
Tapentadol, the new kid on the block in India: Is it time to worry?
Article in Indian journal of psychiatry. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- A very rare case of nasal septal perforation following Tapentadol nasal spray abuse in India.Indian journal of psychiatry · 2025Article
- Tapentadol nasal spray dependence: A reticent subtype of opioid dependence?Indian journal of psychiatry · 2024Article
- Adverse effects from counterfeit and mislabeled medicine containing tapentadol and carisoprodol.Clinical case reports · 2024Article
- Tapentadol dependence through intravenous injection ('shooting') of crushed tablets associated with cutaneous pseudoallergic reactions.BMJ case reports · 2023Article
- Global consumption of prescription opioid analgesics between 2009-2019: a country-level observational study.EClinicalMedicine · 2021Article
- Tapentadol and Zolpidem addiction management with Ayurvedic intervention: A case report.Journal of Ayurveda and integrative medicineArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
objectivesLarge-scale prospective case series of tapentadol abuse or dependence in India is not available. Hence, we aimed to study the prevalence and profile of tapentadol users in a treatment-seeking population. MATERIALS AND
methodsThe study had prospective and retrospective arms. We collected 8-month prospective data by face-to-face interviews (
resultsThe prevalence of tapentadol abuse or dependence was 25% among the pharmaceutical opioid users. Concurrent use of other opioids was seen in >80% of participants of both the arms. Major sources of tapentadol were chemists (without a prescription) (53%) and doctors (prescriptions) (40%). Patients in the tapentadol dependence group had a significantly higher dose, duration, and pharmaceutical opioid use.
conclusionIndia needs awareness promotion, training, availability restriction, and provision of treatment for tapentadol abuse or dependence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.